Johnson & Johnson Deliberately Sold Defective Insulin Pumps
Posted By Defective Medical Device Attorney on Jan 25, 2012 6:00am PST
The U.S. Food and Drug Administration sent a warning letter to Johnson & Johnson on December 27, 2012 after the Animas unit of the company continued to sell insulin pumps last year, despite proof that the insulin pumps were defective and malfunctioning. Animas had started investigating problems with the pumps in April 2011, and yet they continued to sell the malfunctioning pumps during the course of their investigation.
The main problem reported was keypad malfunctions with pumps One Touch Ping and 2020. Animas failed to report the finding of a malfunction to the FDA within 30 days, violating the federal requirement for a malfunction that has the ability to cause or contribute to a death or serious injury. The warning letter that the FDA issued to Animas could result in fines or affect J&J's ability to receive federal contracts in the future.
If you or someone you love has been injured because of a defective insulin pump, contact a defective medical device attorney to learn if your case qualifies for a legal claim. You may be able to seek compensation for the negligence of the manufacturing company and for your injuries as well. A
defective medical device lawyer at our firm will fight for your rights with skilled legal reasoning and tireless defense, so call today for your free consultation.